Fractyl Health, Inc. (GUTS) vs OKYO Pharma Limited (OKYO)

A side-by-side comparison of Fractyl Health, Inc. and OKYO Pharma Limited across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare
Fractyl Health, Inc. logo
GUTS
Fractyl Health, Inc.
$60M
$4.57HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
OKYO Pharma Limited logo
OKYO
OKYO Pharma Limited
$56M
$1.46HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT

Total return — GUTS vs OKYO

growth of $100 · dividends reinvested · last 3y
GUTS -97.0% (-69.1%/yr)OKYO +2.1% (+0.7%/yr)OKYO compounded faster over this window
Log scale — wide-divergence pair
1101001kStart $10020252026$3$102
GUTS OKYO

GUTS vs OKYO: by the numbers

  • •GUTS is the larger company ($60M vs $56M market cap).

Metrics side by side

Valuation

MetricGUTSOKYO
P/B ratioN/A4.54

Profitability

MetricGUTSOKYO
Gross margin0.00%0.00%
Operating margin0.00%0.00%
Net margin0.00%0.00%
ROEN/A-72.55%
ROIC-129.67%-68.91%

Go deeper

Full GUTS analysisFull OKYO analysisInteractive comparison tool

Dig into the metrics

Fractyl Health ROEOKYO Pharma ROEFractyl Health operating marginOKYO Pharma operating marginFractyl Health revenue growthOKYO Pharma revenue growthFractyl Health free cash flowOKYO Pharma free cash flow

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.